OneTestTM is a blood test and machine learning algorithm that was developed to aid in the detection of multiple cancers before symptoms occur when treatments are usually more effective.    

The foundation of OneTest is the measurement of a panel of protein biomarkers. OneTest is not a genetic test that predicts your lifetime risk of cancer.  Instead, it measures a group of tumor-associated proteins secreted by tumors as they grow. These biomarkers have been widely used for cancer screening outside of the U.S., especially in the Far East (Japan, South Korea, China) for over two decades. In that region, tens of millions of individuals receive what are often day-long health check-ups that include blood tests that measure the levels of the same biomarkers that are part of OneTestTM.